Healthcare Press

Older HPV vaccine cuts cervical cancer rate up to 87%, study finds

  • 📰 Reuters
  • ⏱ Reading Time:
  • 27 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 14%
  • Publisher: 97%

Health Health Headlines News

Health Health Latest News,Health Health Headlines

Young women who were vaccinated against human papillomavirus (HPV) in their teens with an older GlaxoSmithKline product called Cervarix had up to an 87% lower risk of developing cervical cancer linked to the virus, a long-running English study found.

Company logo of pharmaceutical company GlaxoSmithKline is seen at their Stevenage facility, Britain October 26, 2020. REUTERS/Matthew Childs

When the vaccinated women were in their 20s, those who had received the series of shots between ages 12 and 13 had cervical cancer rates that were 87% lower than unvaccinated women who had been screened for the malignancy. The findings "should greatly reassure those still hesitant about the benefits of HPV vaccination," the researchers said.

The young women who were vaccinated had around 450 fewer cases of cervical cancers and 17,200 fewer cases of CIN3 than expected in unvaccinated women of the same age.

 

Thank you for your comment. Your comment will be published after being reviewed.
Please try again later.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:

 /  🏆 2. in HEALTH

Health Health Latest News, Health Health Headlines

Similar News:You can also read news stories similar to this one that we have collected from other news sources.

Suffering From Joint Pain? A New Study Suggests Virtual Fitness Classes Can Improve Pain in Older AdultsRemote Fitness Classes Can Improve Pain in Older Adults, New Study Suggests
Source: PreventionMag - 🏆 141. / 63 Read more »